PLASMA-PROTEIN BINDING OF CATECHOLAMINES, PRAZOSIN AND PROPRANOLOL IN DIABETES-MELLITUS

被引:15
作者
TROVIK, TS
JAEGER, R
JORDE, R
INGEBRETSEN, O
SAGER, G
机构
[1] UNIV TROMSO,INST CLIN MED,DEPT INTERNAL MED,N-9001 TROMSO,NORWAY
[2] UNIV TROMSO,INST MED BIOL,DEPT CLIN CHEM,N-9001 TROMSO,NORWAY
关键词
DIABETES-MELLITUS; DRUG PROTEIN BINDING; CATECHOLAMINES; ADRENOCEPTOR BLOCKERS; PRAZOSIN; PROPRANOLOL;
D O I
10.1007/BF02333020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study equilibrium dialysis has been used to determine the degree of protein binding of the catecholamines adrenaline and noradrenalin and the adrenergic receptor blockers, prazosin and propranolol in diabetics. The binding of the catecholamines in plasma from Type I and II diabetic patients was not significantly different from that of healthy subjects. The ratio of the bound and free catecholamine concentrations was correlated with the level of albumin (HSA). Significantly reduced protein binding of prazosin was observed in Type I and II diabetic subjects compared to healthy volunteers. The binding of propranolol was significantly reduced in Type I patients. The ratios between the bound and unbound concentrations of prazosin and propranolol were significantly correlated with the levels of alpha-1-acid glycoprotein (AAG). The results suggest that non-enzymatic glycosylation of plasma proteins may increase the unbound fraction of the adrenergic blockers prazosin and propranolol.
引用
收藏
页码:265 / 268
页数:4
相关论文
共 18 条
[1]  
BARRY MG, 1986, BR J PHARM, V89
[2]   LACK OF HYPOGLYCEMIC SYMPTOMS AND DECREASED BETA-ADRENERGIC SENSITIVITY IN INSULIN-DEPENDENT DIABETIC-PATIENTS [J].
BERLIN, I ;
GRIMALDI, A ;
LANDAULT, C ;
ZOGHBI, F ;
THERVET, F ;
PUECH, AJ ;
LEGRAND, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (02) :273-278
[3]   DECREASED BETA-ADRENERGIC SENSITIVITY IN INSULIN-DEPENDENT DIABETIC SUBJECTS [J].
BERLIN, I ;
GRIMALDI, A ;
BOSQUET, F ;
PUECH, AJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (01) :262-265
[4]   PRAZOSIN BINDING TO HUMAN ALPHA-1-ACID GLYCOPROTEIN (OROSOMUCOID), HUMAN-SERUM ALBUMIN, AND HUMAN-SERUM - FURTHER CHARACTERIZATION OF THE SINGLE DRUG-BINDING SITE OF OROSOMUCOID [J].
BRUNNER, F ;
MULLER, WE .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (05) :305-309
[5]   DIFFERENCES IN THE SERUM-PROTEIN BINDING OF PRAZOSIN IN MAN AND RAT [J].
DALE, O ;
NILSEN, OG .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (11) :1719-1724
[6]   REDUCED EPINEPHRINE SECRETION AND HYPOGLYCEMIA UNAWARENESS IN DIABETIC AUTONOMIC NEUROPATHY [J].
HOELDTKE, RD ;
BODEN, G ;
SHUMAN, CR ;
OWEN, OE .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (04) :459-462
[7]  
KREMER JMH, 1988, PHARMACOL REV, V40, P1
[8]   AGE-ADJUSTED PLASMA NOREPINEPHRINE LEVELS ARE SIMILAR IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS [J].
LAKE, CR ;
ZIEGLER, MG ;
COLEMAN, MD ;
KOPIN, IJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (04) :208-209
[9]   INCREASED LEVELS OF ACUTE-PHASE SERUM-PROTEINS IN DIABETES [J].
MCMILLAN, DE .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (11) :1042-1046
[10]   PRAZOSIN PROTEIN-BINDING IN HEALTH AND DISEASE [J].
RUBIN, P ;
BLASCHKE, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (02) :177-182